{"id":"https://openalex.org/W4223545348","doi":"https://doi.org/10.1111/cbdd.14054","title":"In vitro effects of thirty\u2010eight cardiac drugs on human serum paraoxonase","display_name":"In vitro effects of thirty\u2010eight cardiac drugs on human serum paraoxonase","publication_year":2022,"publication_date":"2022-04-08","ids":{"openalex":"https://openalex.org/W4223545348","doi":"https://doi.org/10.1111/cbdd.14054","pmid":"https://pubmed.ncbi.nlm.nih.gov/35395139"},"language":"en","primary_location":{"id":"doi:10.1111/cbdd.14054","doi":"https://doi.org/10.1111/cbdd.14054","is_oa":false,"landing_page_url":"https://doi.org/10.1111/cbdd.14054","pdf_url":null,"source":{"id":"https://openalex.org/S123587420","display_name":"Chemical Biology & Drug Design","issn_l":"1747-0277","issn":["1747-0277","1747-0285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical Biology & Drug Design","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4223545348"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hdl.handle.net/11508/58032","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027296441","display_name":"Onur Argan","orcid":"https://orcid.org/0000-0001-7745-7736","observed_orcids":["https://orcid.org/0000-0001-7745-7736"]},"institutions":[{"id":"https://openalex.org/I115600380","display_name":"Bal\u0131kesir University","ror":"https://ror.org/02tv7db43","country_code":"TR","type":"education","lineage":["https://openalex.org/I115600380"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Onur Argan","raw_affiliation_strings":["Department of Cardiology, Faculty of Medicine, Balikesir University, Balikesir, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Faculty of Medicine, Balikesir University, Balikesir, Turkey","institution_ids":["https://openalex.org/I115600380"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081442132","display_name":"K\u00fcbra \u00c7\u0131kr\u0131k\u00e7\u0131","orcid":"https://orcid.org/0000-0003-2276-1516","observed_orcids":["https://orcid.org/0000-0003-2276-1516"]},"institutions":[{"id":"https://openalex.org/I115600380","display_name":"Bal\u0131kesir University","ror":"https://ror.org/02tv7db43","country_code":"TR","type":"education","lineage":["https://openalex.org/I115600380"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Kubra Cikrikci","raw_affiliation_strings":["Department of Chemistry, Science and Art Faculty, Balikesir University, Balikesir, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Science and Art Faculty, Balikesir University, Balikesir, Turkey","institution_ids":["https://openalex.org/I115600380"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053992417","display_name":"Harun Uslu","orcid":"https://orcid.org/0000-0001-8827-8557","observed_orcids":["https://orcid.org/0000-0001-8827-8557"]},"institutions":[{"id":"https://openalex.org/I143396566","display_name":"F\u0131rat University","ror":"https://ror.org/05teb7b63","country_code":"TR","type":"education","lineage":["https://openalex.org/I143396566"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Harun Uslu","raw_affiliation_strings":["Department of Medical Services and Techniques, Vocational School of Health Services, Firat University, Elazig, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Services and Techniques, Vocational School of Health Services, Firat University, Elazig, Turkey","institution_ids":["https://openalex.org/I143396566"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038278237","display_name":"Nahit Gen\u00e7er","orcid":"https://orcid.org/0000-0001-7092-8857","observed_orcids":["https://orcid.org/0000-0001-7092-8857"]},"institutions":[{"id":"https://openalex.org/I115600380","display_name":"Bal\u0131kesir University","ror":"https://ror.org/02tv7db43","country_code":"TR","type":"education","lineage":["https://openalex.org/I115600380"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Nahit Gencer","raw_affiliation_strings":["Department of Chemistry, Science and Art Faculty, Balikesir University, Balikesir, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Science and Art Faculty, Balikesir University, Balikesir, Turkey","institution_ids":["https://openalex.org/I115600380"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5027296441"],"corresponding_institution_ids":["https://openalex.org/I115600380"],"apc_list":{"value":3450,"currency":"USD","value_usd":3450},"apc_paid":null,"fwci":0.3714,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.46090535,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"100","issue":"1","first_page":"80","last_page":"89"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12975","display_name":"Paraoxonase enzyme and polymorphisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12975","display_name":"Paraoxonase enzyme and polymorphisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10875","display_name":"Pesticide Exposure and Toxicity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paraoxonase-1","display_name":"paraoxonase 1","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cardiovascular-drugs","display_name":"cardiovascular drugs","score":0.9860000014305115},{"id":"https://openalex.org/keywords/enzyme-inhibitors","display_name":"enzyme inhibitors","score":0.5830000042915344},{"id":"https://openalex.org/keywords/propafenone","display_name":"propafenone","score":0.6690000295639038},{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":0.8999999761581421},{"id":"https://openalex.org/keywords/bisoprolol","display_name":"bisoprolol","score":0.7160000205039978},{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":0.7699999809265137},{"id":"https://openalex.org/keywords/irbesartan","display_name":"irbesartan","score":0.871999979019165},{"id":"https://openalex.org/keywords/nitroglycerin","display_name":"nitroglycerin","score":0.9399999976158142},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.8169999718666077},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6119999885559082},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.7059999704360962}],"concepts":[{"id":"https://openalex.org/C37501387","wikidata":"https://www.wikidata.org/wiki/Q18030661","display_name":"PON1","level":4,"score":0.899986743927002},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7386794090270996},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7106859683990479},{"id":"https://openalex.org/C2776509667","wikidata":"https://www.wikidata.org/wiki/Q7135605","display_name":"Paraoxonase","level":3,"score":0.5352894067764282},{"id":"https://openalex.org/C2779670145","wikidata":"https://www.wikidata.org/wiki/Q412515","display_name":"Bisoprolol","level":3,"score":0.5016303062438965},{"id":"https://openalex.org/C2776428949","wikidata":"https://www.wikidata.org/wiki/Q18814659","display_name":"Ammonium sulfate precipitation","level":4,"score":0.47991880774497986},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.4377760887145996},{"id":"https://openalex.org/C2776525901","wikidata":"https://www.wikidata.org/wiki/Q411325","display_name":"Atenolol","level":3,"score":0.41287896037101746},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2777708172798157},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2240060567855835},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1927250325679779},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.18837136030197144},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1460108757019043},{"id":"https://openalex.org/C193363816","wikidata":"https://www.wikidata.org/wiki/Q1617865","display_name":"Size-exclusion chromatography","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.0},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043303","descriptor_name":"Aryldialkylphosphatase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057927","descriptor_name":"Hydrophobic and Hydrophilic Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/cbdd.14054","doi":"https://doi.org/10.1111/cbdd.14054","is_oa":false,"landing_page_url":"https://doi.org/10.1111/cbdd.14054","pdf_url":null,"source":{"id":"https://openalex.org/S123587420","display_name":"Chemical Biology & Drug Design","issn_l":"1747-0277","issn":["1747-0277","1747-0285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical Biology & Drug Design","raw_type":"journal-article"},{"id":"pmid:35395139","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35395139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical biology & drug design","raw_type":"Journal Article"},{"id":"pmh:oai:openaccess.firat.edu.tr:11508/58032","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11508/58032","pdf_url":null,"source":{"id":"https://openalex.org/S4377196733","display_name":"DSpace - FIRAT (F\u0131rat University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I143396566","host_organization_name":"F\u0131rat University","host_organization_lineage":["https://openalex.org/I143396566"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:openaccess.firat.edu.tr:11508/58032","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11508/58032","pdf_url":null,"source":{"id":"https://openalex.org/S4377196733","display_name":"DSpace - FIRAT (F\u0131rat University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I143396566","host_organization_name":"F\u0131rat University","host_organization_lineage":["https://openalex.org/I143396566"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1756585660","https://openalex.org/W1969048337","https://openalex.org/W1975475382","https://openalex.org/W2028067467","https://openalex.org/W2030326577","https://openalex.org/W2037257784","https://openalex.org/W2047200026","https://openalex.org/W2074631079","https://openalex.org/W2075011939","https://openalex.org/W2077918135","https://openalex.org/W2085227436","https://openalex.org/W2091137061","https://openalex.org/W2100837269","https://openalex.org/W2105668062","https://openalex.org/W2123876228","https://openalex.org/W2125492970","https://openalex.org/W2128635872","https://openalex.org/W2134967712","https://openalex.org/W2150545098","https://openalex.org/W2155238222","https://openalex.org/W2164281974","https://openalex.org/W2169183955","https://openalex.org/W2254923557","https://openalex.org/W2269190601","https://openalex.org/W2311850031","https://openalex.org/W2326692077","https://openalex.org/W2916749530","https://openalex.org/W2950663303","https://openalex.org/W2979037781","https://openalex.org/W3011686755","https://openalex.org/W3200878212"],"related_works":["https://openalex.org/W2002593143","https://openalex.org/W7128916131","https://openalex.org/W4413102040","https://openalex.org/W2979037781","https://openalex.org/W2091290592","https://openalex.org/W3048626055","https://openalex.org/W2755155400","https://openalex.org/W2023665786","https://openalex.org/W2010932277","https://openalex.org/W2562063721"],"abstract_inverted_index":{"Abstract":[0],"In":[1],"this":[2],"study,":[3],"the":[4,13,39,45,70,124,132,164],"effects":[5],"of":[6,38,127,166],"38":[7],"commonly":[8],"used":[9],"cardiac":[10,40,168],"drugs":[11,41,60,121,169],"on":[12,129,170],"human":[14,23],"paraoxonase":[15],"(PON1)":[16],"were":[17,53,138],"investigated.":[18],"PON1":[19,43,63,72,98,105,128,137],"was":[20,67,159],"purified":[21],"from":[22],"serum":[24],"blood":[25],"by":[26],"ammonium":[27],"sulfate":[28],"precipitation":[29],"(60%\u201380%)":[30],"and":[31,50,84,152],"hydrophobic":[32],"interaction":[33],"chromatography":[34],"(Sepharose\u20104B~L\u2010tyrosine~1\u2010napthylamine":[35],"gel).":[36],"All":[37],"inhibited":[42],"at":[44],"micro":[46],"molar":[47],"level.":[48],"IC50":[49],"Ki":[51],"values":[52],"determined":[54],"for":[55],"each":[56],"drug.":[57],"The":[58],"tested":[59],"displayed":[61],"potent":[62,134],"inhibitory":[64,106],"activity.":[65],"It":[66],"found":[68],"that":[69],"weakest":[71],"inhibitors":[73,135],"are":[74],"Irbesartan":[75],"(Ki:":[76,81,86,91,140,144,149,154],"421.73":[77],"\u00b5M),":[78,83,142,146,151],"Glyceryl":[79],"Trinitrate":[80],"351.48":[82],"Apixaban":[85],"333.27":[87],"\u00b5M).":[88,156],"Bisoprolol":[89],"hemifumarate":[90],"269.31":[92],"\u00b5M)":[93],"is":[94],"also":[95,160],"other":[96,120],"weak":[97,104],"inhibitor.":[99],"Therefore,":[100],"these":[101],"drugs,":[102],"having":[103],"activity,":[107],"may":[108],"be":[109],"preferred":[110],"primarily":[111],"in":[112],"patients":[113],"with":[114],"atheroclerotic":[115],"heart":[116],"disease":[117],"compared":[118],"to":[119,123,162],"due":[122],"protective":[125],"effect":[126],"atherosclerosis.":[130],"Conversely,":[131],"most":[133],"against":[136],"propafenone":[139],"0.35":[141],"Lacidipine":[143],"0.78":[145],"Lidocaine":[147],"HCl":[148],"1.78":[150],"Propranolol":[153],"1.86":[155],"Molecular":[157],"docking":[158],"applied":[161],"confirm":[163],"activity":[165],"some":[167],"PON1.":[171]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-04-15T00:00:00"}